A new first-in-human study has validated a PET radiotracer that can effectively image overactive adrenal glands, offering an ...

A new first-in-human study has validated a PET radiotracer that can effectively image overactive adrenal glands, offering an ...

Please provide your email address to receive an email when new articles are posted on . “Although guidelines recommend testing for primary aldosteronism in all patients with treatment-resistant ...

THE hypertension seen in all reported cases of primary aldosteronism caused by an adrenal adenoma has been of a benign and not rapidly progressive nature. 1 On the other hand, an increased secretion ...

Current treatment options for primary aldosteronism are limited to surgery or mineralocorticoid receptor antagonists when surgery isn't an option. In a phase IIa trial, baxdrostat resolved or reduced ...

Please provide your email address to receive an email when new articles are posted on . Primary aldosteronism, an adrenal disorder and a secondary cause of hypertension, has historically been ...

A total of 292 consecutive adult subjects with hypertension or prehypertension visiting the Health Screening Center at KKR Hokuriku Hospital for a general health screening (annual health examination) ...

The Endocrine Society today issued a Clinical Practice Guideline calling on physicians to ramp up screening for primary aldosteronism, a common cause of high blood pressure. The guideline, entitled ...

The Endocrine Society today issued a Clinical Practice Guideline calling on physicians to ramp up screening for primary aldosteronism, a common cause of high blood pressure. People with primary ...

Background. A 57-year-old woman was referred to a nephrology clinic because of chronic hypokalemia. She had a history of polycystic kidney disease, resistant hypertension, atrial fibrillation, type 2 ...

The seated saline suppression test couldn't discriminate between patients with suspected primary aldosteronism who would and would not respond to treatment. Most patients responded to treatment, and ...

Vivek Bhalla, MD, Stanford, calls for greater awareness and implementation of existing screening guidelines to help identify patients who may benefit from more targeted, disease-specific interventions ...